Northwestern Medicine launches institute to address growing demand for lung care
With the growing need for lung care – especially among those suffering long-term effects from COVID-19 – Northwestern Medicine on Thursday launched a new institute to provide thoracic surgery and respiratory medicine.
The Canning Thoracic Institute plans to recruit and educate top physicians in the nation, pioneer new procedures and clinical trials, incorporate artificial intelligence and create a platform to allow patients all over the world to access the health system, said Dr. Scott Budinger, the institute’s medical director and chief of pulmonary and critical care medicine at Northwestern Medicine.
“Our goal was to create solutions for seemingly impossible problems and to be the destination center for disease for diseases of the lung and chest worldwide,” he said. “Since the start of this pandemic, we have been able to respond and demonstrated our strength as an international leader for innovation and breakthrough treatments.”
Dr. Ankit Bharat, executive director of the institute, said it will allow the health system to bring all its resources in one place. Thursday’s launch was helped by a $20 million gift from John and Rita Canning, which Bharat said will “create a center of excellence for the treatment of not just the simple problems but some of the most complex respiratory illnesses and diseases.”
Northwestern Medicine became the first
health system last year to successfully perform the first COVID-19 lung transplant in the United States. It has since completed more than 30 double-lung transplants on COVID-19 patients since June 2020.
